This study was designed to examine the expression of polo-like kinase 1 (PLK1) mRNA in 16 pterygia and 13 normal conjunctival tissue specimens using real-time fluorescent quantitative polymerase chain reaction (PCR). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the housekeeping gene. The difference in threshold cycle value (ΔCt) was derived for PLK1 and GAPDH for each sample assayed, and the difference between the paired samples (ΔΔCt) was calculated. The mean ± SD ΔCt of PLK1 mRNA was 9.56 ± 1.30 in pterygia compared with 10.71 ± 1.39 in normal conjunctiva. The expression of PLK1 mRNA in pterygium was 2.08 - 2.36 times that in normal conjunctiva; this difference was statistically significant. Real-time fluorescent quantitative PCR analysis appears to be effective and sensitive when determining the level of PLK1 mRNA expression. Using this method, it was demonstrated that PLK1 mRNA is over-expressed in pterygia, indicating a probable role for PLK1 in their development.
Di GirolamoNCoroneoMWakefieldD: Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol2005; 167: 489–503.
2.
WongVALawFC: Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians. Opthalmology1999; 106: 1512–1515.
3.
Sánchez-ThorinJCRochaGYelinJB: Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol1998; 82: 661–665.
4.
TanDTLiuYPSunL: Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci2000; 41: 1684–1686.
5.
BauDTChiangCCTsaiYY: Evaluation of transforming growth factor and vascular endothelial growth factor polymorphisms in Taiwan Chinese patients with pterygium. Eur J Ophthalmol2008; 18: 21–26.
6.
SchelliniSAHoyamaEOliveiraDE: Matrix metalloproteinase-9 expression in pterygium. Arq Bras Oftalmol2006; 69: 161–164.
7.
Di GirolamoNWakefieldDCoroneoMT: UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci2006; 47: 2430–2437.
8.
TanDTTangWYLiuYP: Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol2000; 84: 212–216.
9.
WeinsteinORosenthalGZirkinH: Overexpression of p53 tumor suppressor gene in pterygia. Eye2002; 16: 619–621.
10.
SunkelCEGloverDM: Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci1988; 89: 25–38.
11.
EckerdtFYuanJStrebhardtK: Polo-like kinases and oncogenesis. Oncogene2005; 24: 267–276.
12.
LiuXEriksonRL: Polo-like kinase (Plk) 1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA2003; 100: 5789–5794.
13.
GuanRTapangPLeversonJD: Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals. Cancer Res2005; 65: 2698–2704.
14.
YamadaSOhiraMHorieHExpression profiling and differential screening between hepatoblastomas and the corresponding normal livers: Identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene2004; 23: 5901–5911.
15.
ItoYMiyoshiESasakiN: Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. Br J Cancer2004; 90: 414–418.
16.
PeirettiEDessìSMulasC: Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. Invest Ophthalmol Vis Sci2007; 48: 3450–3458.
17.
TsaiYYChengYWLeeH: P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis2005; 11: 50–55.
18.
ShimmuraSIshiokaMHanadaK: Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci2000; 41: 1364–1369.
19.
ChowersIPe'erJZamirE: Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology2001; 108: 985–988.
20.
WeichertWUllrichASchmidtM: Expression patterns of polo-like kinase 1 in human gastric cancer. Cancer Sci2006; 97: 271–276.
21.
Toyoshima-MorimotoFTaniguchiENishidaE: Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep2002; 3: 341–348.
22.
SumaraIVorlauferEStukenbergPT: The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase. Mol Cell2002; 9: 515–525.
23.
GolanAYudkovskyYHershkoA: The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J Biol Chem2002; 277: 15552–15557.
24.
ZhouTAumaisJPLiuX: A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell2003; 5: 127–138.
25.
BuYYangZLiQ: Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. Oncology2008; 74: 198–206.
26.
KaiserKRabodonirinaMPicotS: Real time quantitative PCR and RT-PCR for analysis of Pneumocystis carinii hominis. J Microbiol Methods2001; 45: 113–118.
27.
HuLHChenFHLiYR: Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer. World J Gastroenterol2004; 10: 3514–3517.
